Rode Kruis Ziekenhuis | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,608 results for “Rode Kruis Ziekenhuis”

CUTISS Raises €57.9M Series C to Advance Phase 3 Trial of Personalized Skin Graft Therapy

SOPHiA GENETICS Partners with Belgium's Jessa Ziekenhuis to Advance Precision Oncology Through AI-Driven Genomic Platform

The Fatal Flaw in Pharma's Multi-Million Supply Chain Tech Upgrades: Why Visibility Alone Cannot Build Resilience

TECregen Secures €11M Seed Funding and Appoints New CEO to Advance Thymus Regeneration Therapeutics

TRiCares Announces First U.S. Implantations of Topaz TTVR System in Early Feasibility Study

LIfT BioSciences Appoints New CEO as Company Prepares for Phase 1 Trial of Novel Neutrophil-Based Cancer Immunotherapy

Moderna–Merck mRNA Cancer Therapy Hits Primary Endpoint, Sending Biotech Stocks to Post-Pandemic Highs

SmartCella Expands Extroducer® Licensing Portfolio with Heqet and Oloker Partnerships for Cardiac Regeneration and Refractory Angina

First mRNA Cancer Vaccine Clears Phase 3: Moderna and Merck's Intismeran Autogene Succeeds in Melanoma Trial

Sentinel Lymph Node Biopsy After Neoadjuvant Therapy Shows Promise in Node-Positive Breast Cancer Patients

Page 1 of 19